Baxter beats on Q4 earnings, misses on revenue
Shares in Baxter (NYSE:BAX) held steady today after the medical device maker exceeded earnings expectations on Wall Street with its 4th quarter results, but barely missed revenue estimates. The...
View ArticleBiotronik receives FDA warning on Berlin plant; launches Ilivia CRT-Ds
UPDATED Feb. 1, 2017, with comment from Biotronik. The FDA this week released a warning letter it sent to Biotronik over issues it identified during an inspection of its facilities in Berlin, shortly...
View ArticleExactech deals spine biz to ChoiceSpine
Exactech (NSDQ:EXAC) said it sold off its spine business yesterday to ChoiceSpine for an undisclosed amount and plans to restructure its biologics business. “For nearly a decade, Exactech has driven...
View ArticleInvacare continues restructuring, lays off 100
Invacare (NYSE:IVC) said yesterday it cut 100 employees from its workforce as the company continues to restructure. The Elyria, Ohio-based company said it expects to incur restructuring charges of...
View ArticleGI Dynamics notches German reimbursement win
GI Dynamics (ASX:GID) said today that its EndoBarrier device won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System. This status is the highest of 4 levels, which...
View ArticleStudy finds higher complication risk with Cardinal Health’s Mynx vascular...
A study published last week in The New England Journal of Medicine concluded that patients treated with Cardinal Health (NYSE:CAH)’s Mynx vascular closure device are at higher risk for vascular...
View ArticleVascular Solutions shareholders sue to block $1B Teleflex buyout
A group of Vascular Solutions (NSDQ:VASC) shareholders last week sued to block a $1 billion buyout by Teleflex (NYSE:TFX), arguing that the deal undervalues Vascular Solutions and locks out any...
View ArticleCohero raises $13.3m for connected inhaler tech
Cohero Health said today that it raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. The company sold nearly all of its total offering amount of...
View ArticleMassDevice.com +5 | The top 5 medtech stories for February 1, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleCerulean reviews clinical assets, nanoparticle-drug conjugates
Cerulean Pharma Inc. (NSDQ:CERU) said today that its board of directors launched a strategic review of its assests, considering alternatives for its clinical assets and nanoparticle-drug conjugate...
View ArticleEntellus closes $40m offering
Entellus Medical (NSDQ:ENTL) said today that it closed a $37.2 million underwritten offering with existing stockholders. The company sold 2,353,530 shares of its common stock at $0.001 per share and...
View ArticleEdwards shares lift on Q4, FY2016 earnings beat
Shares in Edwards Lifesciences (NYSE:EW) rose today in after hours trading after the medical device beat expectations on Wall Street with its 4th quarter and full fiscal year 2016 results. The Irvine,...
View Article11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the...
View ArticleHologic shares droop despite Q1 beat
Shares in Hologic (NSDQ:HOLX) fell today in after hours trading despite the medical device maker beating expectations on Wall Street with its 1st quarter results. The Marlborough, Mass.-based company...
View Article5 key takeaways from Emergo’s medical device industry outlook
By Stewart Eisenhart, Emergo Group Emergo’s latest survey of more than 3,000 medical device industry participants finds renewed focus among companies on US and European markets, as well as more bearish...
View ArticleHow to empower your health and wellness customers
Vince Schaller, Managing Director, Schawk (Los Angeles) “Ask your doctor if it’s right for you.” That advice, familiar in the U.S. ever since direct-to-consumer pharmaceutical advertising became legal...
View ArticleBoston Scientific swings to black for Q4, 2016
Boston Scientific (NYSE:BSX) put black ink in the ledger for the 4th quarter and 2016 today, beating the sales and earnings consensus for both periods in the process. The Marlborough, Mass.-based...
View ArticleBecton Dickinson’s Q1 sales, earnings top forecasts
Becton Dickinson & Co. (NYSE:BDX) beat the consensus forecast for both sales and earnings with its fiscal 1st-quarter results, sending share prices up ahead of the open today. Franklin Lakes,...
View ArticleSenate panel confirms Price as HHS chief
The Senate Finance Committee confirmed U.S. Rep. Tom Price (R-Ga.) to head the Health & Humans Services Dept., despite Democrats boycotting the meeting. Republicans on the panel suspended the rule...
View ArticleAdvanced Inhalation Therapies raises $10m
Advanced Inhalation Therapies closed a $10.2 million offering yesterday. According to regulatory filings, 39 investors contributed to the offering, which made its 1st sale on Jan. 13. The Israel-based...
View Article